A federal appeals court has granted the state of Louisiana's request to reinstate a nationwide requirement that abortion pills be dispensed in person. This decision is seen as a victory for opponents of abortion rights, as it restricts access to mifepristone, one of the two pills used in medication abortions. The state challenged the FDA regulation in federal court last year, alleging that the data supporting it was flawed or nonexistent. The FDA had temporarily removed the requirement during the Covid pandemic and made it permanent in 2023. However, Louisiana appealed the decision to the Fifth Circuit, which ruled in its favor.